Skip to main content
Fig. 2 | Antimicrobial Resistance & Infection Control

Fig. 2

From: Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in-vivo study

Fig. 2

Infection clearance rates of MRSA in the Control, Van, NBD + Van, and NBD groups at 6 weeks after debridement. The Control group showed the lowest infection clearance rate, while the highest infection clearance rate was detected in the NBD + Van group. Fisher’s exact test determined statistical significance where *p < 0.05

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us